| New GABAergic interneurons in the adult neocortex and striatum are generated from different precursors AG Dayer, KM Cleaver, T Abouantoun, HA Cameron The Journal of cell biology 168 (3), 415-427, 2005 | 566 | 2005 |
| Programming effects of short prenatal exposure to dexamethasone in sheep M Dodic, T Abouantoun, A O’Connor, EM Wintour, KM Moritz Hypertension 40 (5), 729-734, 2002 | 239 | 2002 |
| Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications JDLSMD Tamara J. Abou-Antoun, James S. Hale Neurotherapeutics, 2017 | 97 | 2017 |
| Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of … TJ Abouantoun, TJ MacDonald Molecular cancer therapeutics 8 (5), 1137-1147, 2009 | 79 | 2009 |
| Cancer cell resistance mechanisms: a mini review S Al-Dimassi, T Abou-Antoun, M El-Sibai Clinical and Translational Oncology 16, 511-516, 2014 | 78 | 2014 |
| Sunitinib induces PTEN expression and inhibits PDGFR signaling and migration of medulloblastoma cells TJ Abouantoun, RC Castellino, TJ MacDonald Journal of neuro-oncology 101, 215-226, 2011 | 59 | 2011 |
| Cancer stem cells in neuroblastoma: expanding the therapeutic frontier HF Bahmad, F Chamaa, S Assi, RM Chalhoub, T Abou-Antoun, ... Frontiers in molecular neuroscience 12, 131, 2019 | 58 | 2019 |
| Reversible adaptive plasticity: a mechanism for neuroblastoma cell heterogeneity and chemo-resistance L Chakrabarti, T Abou-Antoun, S Vukmanovic, AD Sandler Frontiers in oncology 2, 82, 2012 | 47 | 2012 |
| Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration H Zaatiti, J Abdallah, Z Nasr, G Khazen, A Sandler, TJ Abou-Antoun International Journal of Oncology 52 (3), 787-803, 2018 | 40 | 2018 |
| Drug repurposing towards targeting cancer stem cells in pediatric brain tumors HF Bahmad, MK Elajami, T El Zarif, J Bou-Gharios, T Abou-Antoun, ... Cancer and Metastasis Reviews 39 (1), 127-148, 2020 | 37 | 2020 |
| L1-CAM knock-down radiosensitizes neuroblastoma IMR-32 cells by simultaneously decreasing MycN, but increasing PTEN protein expression J Rached, Z Nasr, J Abdallah, T Abou-Antoun International journal of oncology 49 (4), 1722-1730, 2016 | 24 | 2016 |
| Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β HF Bahmad, RM Chalhoub, H Harati, J Bou-Gharios, S Assi, F Ballout, ... Pharmacological Reports 73, 211-226, 2021 | 23 | 2021 |
| Molecular and functional analysis of anchorage independent, treatment-evasive neuroblastoma tumorspheres with enhanced malignant properties: a possible explanation for radio … TJ Abou-Antoun, J Nazarian, A Ghanem, S Vukmanovic, AD Sandler PLoS One 13 (1), e0189711, 2018 | 15 | 2018 |
| Gonadal sex patterns p21-induced cellular senescence in mouse and human glioblastoma L Broestl, NM Warrington, L Grandison, T Abou-Antoun, O Tung, ... Communications biology 5 (1), 781, 2022 | 14 | 2022 |
| A novel mechanism of 17-AAG therapeutic efficacy on HSP90 inhibition in MYCN-amplified neuroblastoma cells R Hanna, J Abdallah, T Abou-Antoun Frontiers in Oncology 10, 624560, 2021 | 12 | 2021 |
| A novel therapeutic mechanism of imipridones ONC201/ONC206 in MYCN-amplified neuroblastoma cells via differential expression of tumorigenic proteins S El-Soussi, R Hanna, H Semaan, AR Khater, J Abdallah, W Abou-Kheir, ... Frontiers in Pediatrics 9, 693145, 2021 | 10 | 2021 |
| Mesenchymal epithelial transition factor signaling in pediatric nervous system tumors: implications for malignancy and cancer stem cell enrichment AR Khater, T Abou-Antoun Frontiers in Cell and Developmental Biology 9, 654103, 2021 | 7 | 2021 |
| Effects of radiotherapy on the risk of developing secondary malignant neoplasms in Hodgkin's lymphoma survivors T Abou-Antoun, R Mikhael, M Massoud, G Chahine, A Saad Asian Pacific Journal of Cancer Prevention 17 (2), 749-754, 2016 | 3 | 2016 |
| Specific inhibition of GSK-3β by Tideglusib: potential therapeutic target for neuroblastoma cancer stem cells HF Bahmad, RM Chalhoub, H Harati, J Bou-Gharios, F Ballout, A Monzer, ... bioRxiv, 2020.02. 18.953596, 2020 | 2 | 2020 |
| KLF5 IS REQUIRED FOR THE SEX-DIFFERENCES ACROSS MULTIPLE TUMORIGENIC PHENOTYPES IN PEDIATRIC GLIOBLASTOMA (GBM) T Abou-Antoun, J Rubin, R Mitra, N Kfoury, X Chen, N Warrington, I Reiss NEURO-ONCOLOGY 24, 122-122, 2022 | | 2022 |
Anthony SandlerChildren's nationalAdresse e-mail validée de cnmc.org
